GE Healthcare Life Sciences and Guangzhou RiboBio, a Guangzhou, China-headquartered oligonucleotide-based biotechnology company, have signed a pact for oligonucleotide drugs.

Under the agreement, GE Healthcare will provide the instrumentation, including its new IN Cell Analyzer 6500HS, a laser-based high-content imaging system, and Äkta OligoProcess (1800 mmole), a large-scale synthesizer system while RiboBio will provide trained scientific staff and support infrastructure.

Source: Guangzhou RiboBio